These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 19025747)

  • 21. Engineering mouse monoclonal antibodies for cancer immunotherapy.
    Orlandi R
    Year Immunol; 1993; 7():69-73. PubMed ID: 8372514
    [No Abstract]   [Full Text] [Related]  

  • 22. Chimeric antibodies.
    Billetta R; Lobuglio AF
    Int Rev Immunol; 1993; 10(2-3):165-76. PubMed ID: 8360583
    [No Abstract]   [Full Text] [Related]  

  • 23. Large-scale production, bacterial localization assessment and immobilized metal affinity chromatography purification of a human single-chain Fv antibody against alphaIIb-beta3 integrin.
    Robert R; Clofent-Sanchez G; Hocquellet A; Jacobin-Valat MJ; Daret D; Noubhani AM; Santarelli X
    Int J Biol Macromol; 2006 Aug; 39(1-3):51-9. PubMed ID: 16620955
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Luminescent terbium protein labels for time-resolved microscopy and screening.
    Rajapakse HE; Reddy DR; Mohandessi S; Butlin NG; Miller LW
    Angew Chem Int Ed Engl; 2009; 48(27):4990-2. PubMed ID: 19492378
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Insight into odorant perception: the crystal structure and binding characteristics of antibody fragments directed against the musk odorant traseolide.
    Langedijk AC; Spinelli S; Anguille C; Hermans P; Nederlof J; Butenandt J; Honegger A; Cambillau C; Plückthun A
    J Mol Biol; 1999 Oct; 292(4):855-69. PubMed ID: 10525411
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Fucose removal from complex-type oligosaccharide enhances the antibody-dependent cellular cytotoxicity of single-gene-encoded antibody comprising a single-chain antibody linked the antibody constant region.
    Natsume A; Wakitani M; Yamane-Ohnuki N; Shoji-Hosaka E; Niwa R; Uchida K; Satoh M; Shitara K
    J Immunol Methods; 2005 Nov; 306(1-2):93-103. PubMed ID: 16236307
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Methotrexate conjugates: a molecular in vivo protein tag.
    Miller LW; Sable J; Goelet P; Sheetz MP; Cornish VW
    Angew Chem Int Ed Engl; 2004 Mar; 43(13):1672-5. PubMed ID: 15038033
    [No Abstract]   [Full Text] [Related]  

  • 28. Sequence analysis and bacterial production of the anti-c-myc antibody 9E10: the V(H) domain has an extended CDR-H3 and exhibits unusual solubility.
    Schiweck W; Buxbaum B; Schätzlein C; Neiss HG; Skerra A
    FEBS Lett; 1997 Sep; 414(1):33-8. PubMed ID: 9305727
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Recombinant single-chain variable fragment antibodies directed against Clostridium difficile toxin B produced by use of an optimized phage display system.
    Deng XK; Nesbit LA; Morrow KJ
    Clin Diagn Lab Immunol; 2003 Jul; 10(4):587-95. PubMed ID: 12853390
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mouse/human chimeric IgE antibodies directed to the house dust mite allergen Der p 2.
    Schuurman J; Lourens TE; Perdok GJ; Parren PW; Aalberse RC
    Int Arch Allergy Immunol; 1995; 107(1-3):465-6. PubMed ID: 7613217
    [No Abstract]   [Full Text] [Related]  

  • 31. A technology platform for the fast production of monoclonal recombinant antibodies against plant proteins and peptides.
    Eeckhout D; De Clercq A; Van De Slijke E; Van Leene J; Stals H; Casteels P; Persiau G; Vercammen D; Van Breusegem F; Zabeau M; Inzé D; Jespers L; Depicker A; De Jaeger G
    J Immunol Methods; 2004 Nov; 294(1-2):181-7. PubMed ID: 15604026
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Making cell-permeable antibodies (Transbody) through fusion of protein transduction domains (PTD) with single chain variable fragment (scFv) antibodies: potential advantages over antibodies expressed within the intracellular environment (Intrabody).
    Heng BC; Cao T
    Med Hypotheses; 2005; 64(6):1105-8. PubMed ID: 15823695
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The importance of the diversity region YYGS motif in anti-DNA antibody binding to DNA.
    Mahmoudi M; Bell DA; Cairns E
    Ann N Y Acad Sci; 1995 Sep; 764():424-6. PubMed ID: 7486557
    [No Abstract]   [Full Text] [Related]  

  • 34. Structural implications of somatic mutations during the immune response to 2-phenyloxazolone.
    Spinelli S; Alzari PM
    Res Immunol; 1994 Jan; 145(1):41-5. PubMed ID: 7516564
    [No Abstract]   [Full Text] [Related]  

  • 35. Mouse/human chimeric Me1-14 antibody: genomic cloning of the variable region genes, linkage to human constant region genes, expression, and characterization.
    Batra SK; Niswonger ML; Wikstrand CJ; Pegram CN; Zalutsky MR; Morrison SL; Bigner DD
    Hybridoma; 1994 Apr; 13(2):87-97. PubMed ID: 8050781
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cloning, sequencing and expression of immunoglobulin variable regions of murine monoclonal antibodies specific for the P1.7 and P1.16 PorA protein loops of Neisseria meningitidis.
    Ihle Ø; Beckstrøm KJ; Michaelsen TE
    Scand J Immunol; 2003 May; 57(5):453-62. PubMed ID: 12753502
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Finding Cinderella's slipper--proteins that fit.
    Ostermeier M; Benkovic SJ
    Nat Biotechnol; 1999 Jul; 17(7):639-40. PubMed ID: 10409352
    [No Abstract]   [Full Text] [Related]  

  • 38. The role of extracellular spacer regions in the optimal design of chimeric immune receptors: evaluation of four different scFvs and antigens.
    Guest RD; Hawkins RE; Kirillova N; Cheadle EJ; Arnold J; O'Neill A; Irlam J; Chester KA; Kemshead JT; Shaw DM; Embleton MJ; Stern PL; Gilham DE
    J Immunother; 2005; 28(3):203-11. PubMed ID: 15838376
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The construction of a mouse/human chimeric antibody against human breast cancer cells.
    Meulemans E; Vandevyver C; Volckaert G; Raus J
    Year Immunol; 1993; 7():131-6. PubMed ID: 8372502
    [No Abstract]   [Full Text] [Related]  

  • 40. Construction and characterization of RNase-based targeted therapeutics.
    Newton DL; Futami J; Ruby D; Rybak SM
    Methods Mol Biol; 2003; 207():283-304. PubMed ID: 12412481
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.